Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.44
Delayed Data
As of 4:02pm ET
 -0.61 / -1.09%
Today’s Change
46.17
Today|||52-Week Range
60.34
-4.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line3.7B4.5B4.7B5.2B
 
 
 
 
 
Depreciation446.4M473.5M495.6M437.7M
 
 
 
 
 
Total Other Cash Flow-358.3M-291.1M808.8M388.3M
 
 
 
 
 
Funds From Operations3.8B4.7B6.0B6.0B
 
 
 
 
 
Funds From/For Other Operating Expenses-47.5M47.3M380.7M319.1M
 
 
 
 
 
Net Cash Flow - Operating Activities3.9B4.6B5.6B5.7B
 
 
 
 
 
 
InvestingIncrease In Investments-86.9M0.000.00-524.0M
 
 
 
Decrease In Investments0.00149.8M401.8M226.6M
 
 
 
 
Capital Expenditures-585.0M-577.5M-707.2M-772.8M
 
 
 
 
 
Fixed Asset Disposal9.2M5.5M709.0K342.9M
 
 
 
 
 
Other Investing - Uses0.000.00-61.2M0.00
 
 
Net Cash Flow Investing-706.1M-494.6M-365.8M-902.1M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-87.1M0.000.000.00
 
 
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-2.1B-2.5B-2.6B-2.5B
 
 
 
 
 
Common Dividends-1.3B-1.7B-2.1B-1.9B
 
 
 
 
 
Cash Dividends Paid - Total-1.3B-1.7B-2.1B-1.9B
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-3.5B-4.2B-4.7B-4.5B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-1.4M-12.5M12.1M12.7M
 
 
 
 
 
 
Net Change In Cash-346.3M-83.8M548.6M308.9M